A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...
Wastewater surveillance suggests that we in the midst of what's being called a "Silent" COVID-19 surge fueled by the XEC ...
Former WHO chief scientist Soumya Swaminathan has reassured that the Human Metapneumovirus (HMPV) is not a cause for concern, ...
Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...
The fear over the spread of HMPV virus that led to concerns if it will trigger Covid-19-like health emergency. Is HMPV same ...
The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...
Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.
While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...
It can take several weeks to bounce back after a bout of COVID-19, but some people develop more persistent problems. The ...
The following is a summary of “Four COVID-19 screening strategies for early case identification within the homeless shelter ...
A new report published in the journal Communications Medicine suggests Pfizer’s (PFE) Paxlovid may help some long Covid patients, but which ...
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement ...